Mark Lesch is a Senior Scientist at Pfizer, La Jolla, where they have worked since 1982. They have focused on developing therapeutic cancer vaccines and immunomodulators since 2007, building on 25 years of experience in the pharmacology of inflammation, rheumatoid arthritis, and osteoarthritis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices